Nova Reader - Subject

Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129

2021-04-11T00:00

The coronavirus disease 2019 (COVID-19) pandemic has been as unprecedented as unexpected, affecting more than 105 million people worldwide as of 8 February 2020 and causing more than 2.3 million deaths according to the World Health Organization (WHO). Not only affecting the lungs but also provoking acute respiratory distress, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is able to infect multiple cell types including cardiac and vascular cells. Hence a significant proportion of infected patients develop cardiac events, such as arrhythmias and heart failure. Patients with cardiovascular comorbidities are at highest risk of cardiac death. To face the pandemic and limit its burden, health authorities have launched several fast-track calls for research projects aiming to develop rapid strategies to combat the disease, as well as longer-term projects to prepare for the future. Biomarkers have the possibility to aid in clinical decision-making and tailoring healthcare in order to improve patient quality of life. The biomarker potential of circulating RNAs has been recognized in several disease conditions, including cardiovascular disease. RNA biomarkers may be useful in the current COVID-19 situation. The discovery, validation, and marketing of novel biomarkers, including RNA biomarkers, require multi-centre studies by large and interdisciplinary collaborative networks, involving both the academia and the industry. Here, members of the EU-CardioRNA COST Action CA17129 summarize the current knowledge about the strain that COVID-19 places on the cardiovascular system and discuss how RNA biomarkers can aid to limit this burden. They present the benefits and challenges of the discovery of novel RNA biomarkers, the need for networking efforts, and the added value of artificial intelligence to achieve reliable advances.

Sublimable Spin‐Crossover Complexes: From Spin‐State Switching to Molecular Devices

2020-10-29T00:00

Spin‐crossover (SCO) active transition metal complexes are an important class of switchable molecular materials due to their bistable spin‐state switching characteristics at or around room temperature. Vacuum‐sublimable SCO complexes are a subclass of SCO complexes suitable for fabricating ultraclean spin‐switchable films desirable for applications, especially in molecular electronics/spintronics. Consequently, on‐surface SCO of thin‐films of sublimable SCO complexes have been studied employing spectroscopy and microscopy techniques, and results of fundamental and technological importance have been obtained. This Review provides complete coverage of advances made in the field of vacuum‐sublimable SCO complexes: progress made in the design and synthesis of sublimable functional SCO complexes, on‐surface SCO of molecular and multilayer thick films, and various molecular and thin‐film device architectures based on the sublimable SCO complexes.

This review provides a complete account of the on‐surface spin‐state switching behavior of films of spin‐crossover (SCO) complexes of molecular to multilayer thickness. SCO‐based molecular and thin‐film device architectures fabricated employing vacuum sublimation are also described.

Acid–Base Free Main Group Carbonyl Analogues

2020-10-19T00:00

Main group carbonyl analogues (R₂E=O) derived from p‐block elements (E=groups 13 to 15) have long been considered as elusive species. Previously, employment of chemical tricks such as acid‐ and base‐stabilization protocols granted access to these transient species in their masked forms. However, electronic and steric effects inevitably perturb their chemical reactivity and distinguish them from classical carbonyl compounds. A new era was marked by the recent isolation of acid–base free main group carbonyl analogues, ranging from a lighter boracarbonyl to the heavier silacarbonyls, phosphacarbonyls and a germacarbonyl. Most importantly, their unperturbed nature elicits exciting new chemistry, spanning the vista from classical organic carbonyl‐type reactions to transition metal‐like oxide ion transfer chemistry. In this Review, we survey the strategies used for the isolation of such systems and document their emerging reactivity profiles, with a view to providing fundamental comparisons both with carbon and transition metal oxo species. This highlights the emerging opportunities for exciting “crossover” reactivity offered by these derivatives of the p‐block elements.

Recently, hitherto elusive acid‐ and base‐free main group carbonyl analogues (R₂E=O) derived from group 13 to 15 elements have been isolated in crystalline form. Their unperturbed nature elicits exciting new chemistry, spanning the vista from classical organic carbonyl‐type reactions to transition metal‐like oxide ion transfer chemistry.

Molecular Vanadium Oxides for Energy Conversion and Energy Storage: Current Trends and Emerging Opportunities

2020-12-17T00:00

Molecular vanadium oxides, or polyoxovanadates (POVs), have recently emerged as a new class of molecular energy conversion/storage materials, which combine diverse, chemically tunable redox behavior and reversible multielectron storage capabilities. This Review explores current challenges, major breakthroughs, and future opportunities in the use of POVs for energy conversion and storage. The reactivity, advantages, and limitations of POVs are explored, with a focus on their use in lithium and post‐lithium‐ion batteries, redox‐flow batteries, and light‐driven energy conversion. Finally, emerging themes and new research directions are critically assessed to provide inspiration for how this promising materials class can advance research in sustainable energy technologies.

This Review critically discusses recent breakthroughs and future challenges in research on polyoxovanadate energy materials. The use of polyoxovanadates in batteries, redox‐flow batteries, light‐driven catalysis, and electrocatalysis is described together with an outlook on emerging themes and areas of future application.

Bilateral Pallidotomy for Dystonia: A Systematic Review

2020-11-20T00:00

Stereotactic lesioning of the bilateral globus pallidus (GPi) was one of the first surgical treatments for medication‐refractory dystonia but has largely been abandoned in clinical practice after the introduction of deep brain stimulation (DBS). However, some patients with dystonia are not eligible for DBS. Therefore, we reviewed the efficacy, safety, and sustainability of bilateral pallidotomy by conducting a systematic review of individual patient data (IPD). Guidelines of the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses and IPD were followed. In May 2020, Medline, Embase, Web of Science, and Cochrane Library were searched for studies reporting on outcome of bilateral pallidotomy for dystonia. If available, IPD were collected. In this systematic review, 100 patients from 33 articles were evaluated. Adverse events were reported in 20 patients (20%), of which 8 were permanent (8%). Pre‐and postoperative Burke‐Fahn‐Marsden Dystonia Rating Movement Scale scores were available for 53 patients. A clinically relevant improvement (>20%) of this score was found in 42 of 53 patients (79%). Twenty‐five patients with status dystonicus (SD) were described. In all but 2 the SD resolved after bilateral pallidotomy. Seven patients experienced a relapse of SD. Median‐reported follow‐up was 12 months (n = 83; range: 2–180 months). Based on the current literature, bilateral pallidotomy is an effective and relatively safe procedure for certain types of dystonia, particularly in medication‐refractory SD. Although due to publication bias the underreporting of negative outcomes is very likely, bilateral pallidotomy is a reasonable alternative to DBS in selected dystonia patients. © 2020 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Data Sharing Under the General Data Protection Regulation

2021-02-15T00:00

Supplemental Digital Content is available in the text.

The General Data Protection Regulation (GDPR) became binding law in the European Union Member States in 2018, as a step toward harmonizing personal data protection legislation in the European Union. The Regulation governs almost all types of personal data processing, hence, also, those pertaining to biomedical research. The purpose of this article is to highlight the main practical issues related to data and biological sample sharing that biomedical researchers face regularly, and to specify how these are addressed in the context of GDPR, after consulting with ethics/legal experts. We identify areas in which clarifications of the GDPR are needed, particularly those related to consent requirements by study participants. Amendments should target the following: (1) restricting exceptions based on national laws and increasing harmonization, (2) confirming the concept of broad consent, and (3) defining a roadmap for secondary use of data. These changes will be achieved by acknowledged learned societies in the field taking the lead in preparing a document giving guidance for the optimal interpretation of the GDPR, which will be finalized following a period of commenting by a broad multistakeholder audience. In parallel, promoting engagement and education of the public in the relevant issues (such as different consent types or residual risk for re-identification), on both local/national and international levels, is considered critical for advancement. We hope that this article will open this broad discussion involving all major stakeholders, toward optimizing the GDPR and allowing a harmonized transnational research approach.

Iridium‐Catalysed C−H Borylation of Heteroarenes: Balancing Steric and Electronic Regiocontrol

2020-11-03T00:00

The iridium‐catalysed borylation of aromatic C−H bonds has become the preferred method for the synthesis of aromatic organoboron compounds. The reaction is highly efficient, tolerant of a broad range of substituents and can be applied to both carbocyclic and heterocyclic substrates. The regioselectivity of C−H activation is dominated by steric considerations and there have been considerable efforts to develop more selective processes for less constrained substrates. However, most of these have focused on benzenoid‐type substrates and in contrast, heteroarenes remain much desired but more challenging substrates with the position and/or nature of the heteroatom(s) significantly affecting reactivity and regioselectivity. This review will survey the borylation of heteroarenes, focusing on the influence of steric and electronic effects on regiochemical outcome and, by linking to current mechanistic understandings, will provide insights to what is currently possible and where further developments are required.

Which C−H bond? The iridium‐catalysed C−H borylation reaction is a powerful method for the preparation of aromatic organoboronate esters. Sterically regulated regioselectivity dominates carbocyclic aromatic C−H borylation. In contrast, heterocyclic aromatics display a much greater influence from electronic effects. In this review, examples of heterocyclic C−H borylation are surveyed, and the origins of heterocyclic C−H borylation regioselectivities discussed.

Understanding the Interaction of Polyelectrolyte Architectures with Proteins and Biosystems

2020-10-27T00:00

The counterions neutralizing the charges on polyelectrolytes such as DNA or heparin may dissociate in water and greatly influence the interaction of such polyelectrolytes with biomolecules, particularly proteins. In this Review we give an overview of studies on the interaction of proteins with polyelectrolytes and how this knowledge can be used for medical applications. Counterion release was identified as the main driving force for the binding of proteins to polyelectrolytes: Patches of positive charge become multivalent counterions of the polyelectrolyte and lead to the release of counterions from the polyelectrolyte and a concomitant increase in entropy. This is shown from investigations on the interaction of proteins with natural and synthetic polyelectrolytes. Special emphasis is paid to sulfated dendritic polyglycerols (dPGS). The Review demonstrates that we are moving to a better understanding of charge–charge interactions in systems of biological relevance. Research along these lines will aid and promote the design of synthetic polyelectrolytes for medical applications.

Polyelectrolytes such as DNA or heparin are long linear or branched macromolecules onto which charges are appended. The counterions neutralizing these charges can dissociate in water and this will largely determine the interaction of such polyelectrolytes with biomolecules, particularly with proteins. This Review discusses studies on the interaction of proteins with polyelectrolytes and how this knowledge can be used for medical applications.

Starting Antihypertensive Drug Treatment With Combination Therapy

2021-02-11T00:00

Supplemental Digital Content is available in the text.

Biocatalysis: Enzymatic Synthesis for Industrial Applications

2020-08-17T00:00

Biocatalysis has found numerous applications in various fields as an alternative to chemical catalysis. The use of enzymes in organic synthesis, especially to make chiral compounds for pharmaceuticals as well for the flavors and fragrance industry, are the most prominent examples. In addition, biocatalysts are used on a large scale to make specialty and even bulk chemicals. This review intends to give illustrative examples in this field with a special focus on scalable chemical production using enzymes. It also discusses the opportunities and limitations of enzymatic syntheses using distinct examples and provides an outlook on emerging enzyme classes.

Biocatalysis has developed into a mature technology for chemical and pharmaceutical synthesis as well as other areas where high selectivity and mild reaction conditions are required. This Review highlights recent achievements with a special focus on industrialized applications including the introduction of key performance indicators (KPIs) to judge the efficiency of enzymes.

Challenges and Strategies for High‐Energy Aqueous Electrolyte Rechargeable Batteries

2020-07-16T00:00

Aqueous rechargeable batteries are becoming increasingly important to the development of renewable energy sources, because they promise to meet cost‐efficiency, energy and power demands for stationary applications. Over the past decade, efforts have been devoted to the improvement of electrode materials and their use in combination with highly concentrated aqueous electrolytes. Here the latest ground‐breaking advances in using such electrolytes to construct aqueous battery systems efficiently storing electrical energy, i.e., offering improved energy density, cyclability and safety, are highlighted. This Review aims to timely provide a summary of the strategies proposed so far to overcome the still existing hurdles limiting the present aqueous batteries technologies employing concentrated electrolytes. Emphasis is placed on aqueous batteries for lithium and post‐lithium chemistries, with potentially improved energy density, resulting from the unique advantages of concentrated electrolytes.

A matter of concentration: The latest ground‐breaking advances and strategies of using concentrated electrolyte for aqueous batteries, are discussed. Emphasis is placed on aqueous batteries for lithium and post‐lithium chemistries, with improved energy density, resulting from the unique properties of salt‐concentrated electrolytes.

Molecular mechanisms and physiological functions of mitophagy

2021-01-13T00:00

Degradation of mitochondria via a selective form of autophagy, named mitophagy, is a fundamental mechanism conserved from yeast to humans that regulates mitochondrial quality and quantity control. Mitophagy is promoted via specific mitochondrial outer membrane receptors, or ubiquitin molecules conjugated to proteins on the mitochondrial surface leading to the formation of autophagosomes surrounding mitochondria. Mitophagy‐mediated elimination of mitochondria plays an important role in many processes including early embryonic development, cell differentiation, inflammation, and apoptosis. Recent advances in analyzing mitophagy in vivo also reveal high rates of steady‐state mitochondrial turnover in diverse cell types, highlighting the intracellular housekeeping role of mitophagy. Defects in mitophagy are associated with various pathological conditions such as neurodegeneration, heart failure, cancer, and aging, further underscoring the biological relevance. Here, we review our current molecular understanding of mitophagy, and its physiological implications, and discuss how multiple mitophagy pathways coordinately modulate mitochondrial fitness and populations.

This review describes the conserved pathways for mitochondrial degradation via selective autophagy across species, and how multiple mitophagy pathways cooperate to modulate mitochondrial fitness and number in normal or disease physiology.

Prospects of Coupled Organic–Inorganic Nanostructures for Charge and Energy Transfer Applications

2020-09-17T00:00

We review the field of organic–inorganic nanocomposites with a focus on materials that exhibit a significant degree of electronic coupling across the hybrid interface. These nanocomposites undergo a variety of charge and energy transfer processes, enabling optoelectronic applications in devices which exploit singlet fission, triplet energy harvesting, photon upconversion or hot charge carrier transfer. We discuss the physical chemistry of the most common organic and inorganic components. Based on those we derive synthesis and assembly strategies and design criteria on material and device level with a focus on photovoltaics, spin memories or optical upconverters. We conclude that future research in the field should be directed towards an improved understanding of the binding motif and molecular orientation at the hybrid interface.

This Review provides an overview of the field of organic–inorganic nanocomposites with a focus on materials that exhibit a significant degree of electronic coupling across the hybrid interface. The characteristic properties of these nanocomposites pave the way to potential optoelectronic applications in devices which exploit singlet fission, triplet energy harvesting, photon upconversion or hot charge carrier transfer.

Ambulatory Blood Pressure Monitoring to Diagnose and Manage Hypertension

2021-01-04T00:00

This review portrays how ambulatory blood pressure (BP) monitoring was established and recommended as the method of choice for the assessment of BP and for the rational use of antihypertensive drugs. To establish much-needed diagnostic ambulatory BP thresholds, initial statistical approaches evolved into longitudinal studies of patients and populations, which demonstrated that cardiovascular complications are more closely associated with 24-hour and nighttime BP than with office BP. Studies cross-classifying individuals based on ambulatory and office BP thresholds identified white-coat hypertension, an elevated office BP in the presence of ambulatory normotension as a low-risk condition, whereas its counterpart, masked hypertension, carries a hazard almost as high as ambulatory combined with office hypertension. What clinically matters most is the level of the 24-hour and the nighttime BP, while other BP indexes derived from 24-hour ambulatory BP recordings, on top of the 24-hour and nighttime BP level, add little to risk stratification or hypertension management. Ambulatory BP monitoring is cost-effective. Ambulatory and home BP monitoring are complimentary approaches. Their interchangeability provides great versatility in the clinical implementation of out-of-office BP measurement. We are still waiting for evidence from randomized clinical trials to prove that out-of-office BP monitoring is superior to office BP in adjusting antihypertensive drug treatment and in the prevention of cardiovascular complications. A starting research line, the development of a standardized validation protocol for wearable BP monitoring devices, might facilitate the clinical applicability of ambulatory BP monitoring.

Chemical Modification of Reducing End‐Groups in Cellulose Nanocrystals

2020-09-09T00:00

Native plant cellulose has an intrinsic supramolecular structure. Consequently, it can be isolated as nanocellulose species, which can be utilized as building blocks for renewable nanomaterials. The structure of cellulose also permits its end‐wise modification, i.e., chemical reactions exclusively on one end of a cellulose chain or a nanocellulose particle. The premises for end‐wise modification have been known for decades. Nevertheless, different approaches for the reactions have emerged only recently, because of formidable synthetic and analytical challenges associated with the issue, including the adverse reactivity of the cellulose reducing end and the low abundance of newly introduced functionalities. This Review gives a full account of the scientific underpinnings and challenges related to end‐wise modification of cellulose nanocrystals. Furthermore, we present how the chemical modification of cellulose nanocrystal ends may be applied to directed assembly, resulting in numerous possibilities for the construction of new materials, such as responsive liquid crystal templates and composites with tailored interactions.

Topochemical modifications at the reducing end of nanocellulose are a new trend in cellulose materials research. The chemistry is aldehyde‐specific and exploits the inherent directionality of the chains in the cellulose I crystal bearing aldehyde groups exclusively on one end. This Review discusses challenges related to end‐specific modifications and highlights the opportunities for nanocellulose materials.

Mechanisms of small cell lung cancer metastasis

2020-12-09T00:00

Metastasis is a major cause of morbidity and mortality in cancer patients. However, the molecular and cellular mechanisms underlying the ability of cancer cells to metastasize remain relatively poorly understood. Among all solid tumors, small cell lung cancer (SCLC) has remarkable metastatic proclivity, with a majority of patients diagnosed with metastatic disease. Our understanding of SCLC metastasis has been hampered for many years by the paucity of material from primary tumors and metastases, as well as the lack of faithful pre‐clinical models. Here, we review recent advances that are helping circumvent these limitations. These advances include methods that employ circulating tumor cells from the blood of SCLC patients and the development of diverse genetically engineered mouse models of metastatic SCLC. New insights into the cellular mechanisms of SCLC metastasis include observations of cell fate changes associated with increased metastatic ability. Ongoing studies on cell migration and organ tropism promise to expand our understanding of SCLC metastasis. Ultimately, a better molecular understanding of metastatic phenotypes may be translated into new therapeutic options to limit metastatic spread and treat metastatic SCLC.

Small cell lung cancer (SCLC) is highly metastatic, but rare resections of SCLC tumors and metastases have hampered our understanding of SCLC progression. This review offers a comprehensive overview of recent advances on models and mechanisms of SCLC metastasis.